Starpharma Holdings Limited

ASX:SPL.AX

0.1 (AUD) • At close November 5, 2024
Bedrijfsnaam Starpharma Holdings Limited
Symbool SPL.AX
Munteenheid AUD
Prijs 0.1
Beurswaarde 41,810,700
Dividendpercentage 0%
52-weken bereik 0.086 - 0.195
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), GAICD, MBA
Website https://starpharma.com

An error occurred while fetching data.

Over Starpharma Holdings Limited

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral

Vergelijkbare Aandelen

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.975 AUD

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.56 AUD

Immutep Limited logo

Immutep Limited

IMM.AX

0.28 AUD

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.585 AUD

Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

PAR.AX

0.22 AUD

Capitol Health Limited logo

Capitol Health Limited

CAJ.AX

0.36 AUD

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.83 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.1 AUD

Trajan Group Holdings Limited logo

Trajan Group Holdings Limited

TRJ.AX

1.155 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)